Research News and Research

RSS

Programme on surgical and medical treatment strategies for cancer

The 5th ESU Master class on medical treatment for urological cancer is organised by the European School of Urology (ESU) on 25-27 June 2010 at the Barcel- Hotel Sants in Barcelona, Spain.

11 Jun 2010

INPC to include post-acute care facilities for individuals with significant health care needs

The Indiana Network for Patient Care, one of the highest volume health information exchanges in the United States, is expanding to include post-acute care facilities, bringing the benefits of secure health information exchange to a growing number of individuals who often have significant health care needs.

11 Jun 2010

New book provides overview of paediatric drug development

Children in the developed world have never enjoyed better medical care: mortality has decreased and many fatal diseases of the past can today be prevented or even cured. However, the current practice of pharmacotherapy in children does not reflect existing scientific knowledge and has come under scrutiny by paediatricians, pharmacists and regulatory authorities. In order to advance the development of medicines tailored to paediatric needs, US and EU legislators have taken action, and the WHO has initiated a global paediatric campaign.

11 Jun 2010

PPMD to fund two promising research initiatives in Duchenne muscular dystrophy

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today that PPMD will be funding two critical, promising research initiatives in Duchenne.

11 Jun 2010

Older breast cancer women in Scotland do not receive same level of treatment as younger patients

Older women in Scotland who have been diagnosed with breast cancer do not always receive the same level of treatment as younger patients, the charity Breakthrough Breast Cancer has said. According to the charity, Scottish women over the age of 80 are 40 times less likely to be offered surgery, chemotherapy and radiotherapy for breast cancer.

11 Jun 2010

Pfizer to join SGC-led collaboration to generate chemical probes for proteins involved in epigenetic signalling

The Structural Genomics Consortium (SGC) and Pfizer today announced that Pfizer will join the SGC-led public-private collaboration to generate small molecule inhibitors - "chemical probes" - for proteins involved in epigenetic signalling.

11 Jun 2010

Study offers new insights into how brain chooses between behaviors that are critical for survival

A team of biologists has isolated genes that regulate the sleep-feeding conflict. The study, which appears in the latest issue of the journal Current Biology, offers new insights into how the brain chooses between behaviors that are critical for survival.

11 Jun 2010

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

The World Health Organization (WHO), in consultation with the government of the United Kingdom, has designated the Liverpool School of Tropical Medicine (LSTM) as a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases.

11 Jun 2010

Ashikari Breast Center to participate in TARGiT intra-operative radiotherapy trial

The Ashikari Breast Center at The Dobbs Ferry Pavilion of St. John's Riverside Hospital today announced its participation in two new groundbreaking studies that may alter the care for early breast cancer.

11 Jun 2010

Ginkgo extract EGb 761 promotes formation of new nerve cells, cell connections in brain's memory center

US scientists have shown that the Ginkgo extract EGb 761® promotes the formation of new nerve cells and new cell connections in the hippocampus, the brain's memory center. According to Professor Yuan Luo from the University of Maryland, Baltimore, the Ginkgo constituents responsible for these effects are quercetin and bilobalide.

11 Jun 2010

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.

11 Jun 2010

Helix BioPharma third-quarter revenues increase 20.6%

Helix BioPharma Corp. today announced financial results for the third quarter ended April 30, 2010.

11 Jun 2010

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

The draft conclusions for the U.N.'s Millennium Development Goals (MDGs) summit in September, which were distributed to governments last week, call on world leaders to follow through on promises of aid money to help countries reach the benchmarks established in 2000, Reuters reports.

11 Jun 2010

Sharron Davies unveils new Nottingham Respiratory BRU Clinical Trials Unit

Olympic swimmer and television personality Sharron Davies MBE was in Nottingham this week to open a new clinical trials unit that will take treatments for respiratory illnesses such as asthma from laboratory bench to bedside.

11 Jun 2010

Botox reduces short-term pain in thoracic outlet syndrome patients

Made popular for its ability to smooth wrinkles when injected into the face, Botox - a toxin known to weaken or paralyze certain nerves and muscles - may have another use that goes beyond the cosmetic.

11 Jun 2010

Women Deliver conference concludes

The Women Deliver conference concluded on Wednesday, as attendees "celebrated benchmark achievements in reducing maternal and infant mortality and faced stubborn failures at the same time," Womens eNews reports.

11 Jun 2010

Type 2 diabetes doubles risk of cancer in women

Type 2 adult-onset diabetes causes insulin-like hormones to circulate through the body. A new study finds this has a surprisingly positive effect on reducing the rate of prostate cancer in men, but is bad news for women: Type 2 diabetes may double the risk of female genital and other cancers.

11 Jun 2010

Study identifies mechanism that interrupts normal p53 gene function leading to tumor development

The p53 gene has been a well-documented player in the prevention of tumors. It is considered the most frequently mutated gene in human tumors with more than half harboring p53 mutations (Bennett et al., 1999). These mutations often can be caused by disruption in normal p53 function.

11 Jun 2010

Bevacizumab increases risk for proteinuria in cancer patients

Cancer patients treated with the chemotherapy agent bevacizumab (Avastin) may be at an increased risk of severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment. This conclusion stems from a study of more than 12,000 patients by Shenhong Wu, M.D., Ph.D., Principal Investigator, and colleagues at Stony Brook University Medical Center. Their findings are reported in online June 10 in the Journal of the American Society Nephrology (JASN).

11 Jun 2010

WHO Director-General responds to criticisms over agency's H1N1 response

WHO Director-General Margaret Chan on Tuesday rejected recent criticisms that her decisions to declare H1N1 (swine flu) a pandemic were impacted by her advisers' link to the pharmaceutical industry, the Associated Press reports.

11 Jun 2010

Research News and Research

Programme on surgical and medical treatment strategies for cancer

INPC to include post-acute care facilities for individuals with significant health care needs

New book provides overview of paediatric drug development

PPMD to fund two promising research initiatives in Duchenne muscular dystrophy

Older breast cancer women in Scotland do not receive same level of treatment as younger patients

Pfizer to join SGC-led collaboration to generate chemical probes for proteins involved in epigenetic signalling

Study offers new insights into how brain chooses between behaviors that are critical for survival

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

Ashikari Breast Center to participate in TARGiT intra-operative radiotherapy trial

Ginkgo extract EGb 761 promotes formation of new nerve cells, cell connections in brain's memory center

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Helix BioPharma third-quarter revenues increase 20.6%

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

Sharron Davies unveils new Nottingham Respiratory BRU Clinical Trials Unit

Botox reduces short-term pain in thoracic outlet syndrome patients

Women Deliver conference concludes

Type 2 diabetes doubles risk of cancer in women

Study identifies mechanism that interrupts normal p53 gene function leading to tumor development

Bevacizumab increases risk for proteinuria in cancer patients

WHO Director-General responds to criticisms over agency's H1N1 response

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence